DAVA SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Endava plc (DAVA) Investors of Securities Class Action Lawsuit Deadline on November 30, 2026

Faruqi & Faruqi said it is investigating potential claims against Endava and noted that a federal securities class action has been filed against the company. Investors have until November 30, 2026, to seek appointment as lead plaintiff; the firm is contacting investors who acquired Endava securities from September 4, 2025, through September 21, 2026.

Analysis

This is a procedural litigation notice, not evidence that the allegations are substantiated or that Endava’s financial statements or outlook have changed. The lead-plaintiff deadline may create intermittent headline pressure on DAVA through November 30, but it is not itself a merits ruling or a reliable measure of potential damages. The key market transmission would be any complaint alleging a specific, financially material misrepresentation: that could raise disclosure-control questions, increase legal and compliance costs, and make investors discount management guidance until the claims are resolved. None of those details or their financial magnitude is established here. Over the next 1–3 months, monitor the complaint, court filings, and any company response for alleged conduct, relevant periods, and quantified exposure; over 6–18 months, the issue matters more if it expands into restatements, regulatory scrutiny, or demonstrable customer and employee friction. A contrarian read is that law-firm solicitation headlines can look more consequential than their incremental information content. Do not infer liability or trade the notice as a standalone fundamental catalyst.

Key Decisions for Investors

• No standalone short recommendation on this notice. Treat any DAVA weakness driven only by solicitation headlines as a watch item, not confirmation of deteriorating fundamentals.
• Before changing exposure, verify the filed complaint’s specific allegations, alleged corrective disclosures, class-period basis, and any claimed financial impact; distinguish allegations from adjudicated facts.
• Reassess if court filings or company disclosures indicate restatement risk, material control deficiencies, regulatory involvement, or a guidance change. Those would provide a stronger basis for updating the fundamental thesis.
• Falsification of a litigation-driven bearish view: the claims are narrowed or dismissed and operating indicators and guidance remain intact. Conversely, expanded claims or evidence of customer, employee, or reporting disruption would increase downside risk.